Catalog Peptides Market: By Type, By Application, By End User, and Geography   

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Catalog Peptides Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Cyclic, Calcitonin Gene-Related, Caspase Related, Amyloid, Adrenomedullin, Amylin, Tau, Cosmetic, Anti-microbial, GPCR and Others), By Application (Commercial, Academic Research, Therapeutics), By End User (Pharmaceutical and Biotechnology Companies, CRO&CMO, Academic and Research Institute), and Region   

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Catalog Peptides Market size was valued at US$ 235.59 million in 2022 and is poised to grow at a CAGR of 8% from 2023-2029. The catalog peptide market is witnessing growth due to technological advances that aid in the cost-effective manufacture of peptides. Previously, peptides were synthesized from natural sources such as porcine-derived adrenocorticotropic hormone (ACTH) or bovine pituitary, and bovine or canine pancreatic insulin. Growing research activities to address unmet medical needs in various therapeutic areas, raising the burden of chronic diseases, and increasing investment and funding for protein-based research are among the key factors driving the market growth. Nevertheless, the absence of a coherent collection of regulations restrains business development.  

Catalog Peptides Market key Developments:
  • In February 2017 to expand its product portfolio by incorporating proteins, antibodies, and enzyme-linked immunosorbent assays (ELISA) into GenWay's product portfolio and to become a key provider of proteomic solutions on the market.
  • In January 2017, the PolyPeptide Group announced the completion of its acquisition of the peptides business and operations of Lonza in Braine-Alleud, Belgium.

summary download arrow Download Free Sample

Catalog Peptides Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

8%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Catalog Peptides Market Dynamics

Recently there has been an increase in the number of research activities undertaken, especially in the areas of drug development, antibody production, disease research, and therapy. The increased emphasis on these areas allows for the revealing of novel techniques, many of which involve peptide use and synthesis. The increase in the number of research activities can be attributed to the rising demand for catalogue peptides which further increases the market share of the global catalogue peptides.

Catalog Peptides Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2022

US$ 235.59 million

Market CAGR

8%

By Technique

  • Cyclic
  • Calcitonin gene-related
  • Caspase related
  • Amyloid
  • Adrenomedullin
  • Amylin
  • Tau
  • Cosmetic
  • Anti-microbial
  • G-protein-coupled receptors (GPCR)
  • Others

By Application

  • Commercial
    • Antibody production
    • Drug discovery
    • Enzyme profiling
    • Others
  • Academic Research
    • Disease research
      • Cancer and apoptosis
      • Cardiovascular
      • Diabetes
      • Neuroscience
      • Infectious diseases
      • Anti-inflammatory
      • Blood disorders
      • Others
    • Biomarker discovery
    • Others
  • Therapeutics

By Region

  • Pharmaceutical and Biotechnology Companies
  • Contract manufacturing organizations (CMOs) and Contract research organizations (CROs)
  • Academic and Research Institutes

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Key Features of the Report

  • The catalog peptides market report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global catalog peptides market size was valued at usd 235.59 million in 2022

The catalog peptides market key players are PolyPeptide Group, CSBio, GL Biochem Ltd., CPC Scientific Inc., Peptides International Ltd., Applied Biological Materials Inc.

North America is dominating the catalog peptides market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Catalog Peptide Market Introduction
2.1. Global Catalog Peptide Market Taxonomy
2.2. Global Catalog Peptide Market Definitions
2.2.1. By Peptide Type
2.2.2. By Disease Type
2.2.3. By Application
2.2.4. By End User
2.2.5. By Region
3. Global Catalog Peptide Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Catalog Peptide Market Dynamic Factors - Impact Analysis
3.6. Global Catalog Peptide Market Competition Landscape
4. Global Catalog Peptide Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Catalog Peptide Market, By Peptide Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1. Adrenomedullin
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. G-Protein-Coupled Receptors (GPCR)
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Amyloid
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Caspase Related
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Calcitonin Gene-Related
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Cyclic
5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Amylin
5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Tau
5.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Others
5.9.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
6. Global Catalog Peptide Market, By Disease Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1. Cancer and Apoptosis
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Cardiovascular
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Diabetes
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Neuroscience
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Infectious Diseases
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Anti-inflammatory
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Blood Disorders
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
6.8. Others
6.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.8.3. Market Opportunity Analysis
7. Global Catalog Peptide Market, By Application, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1. Antibody Production
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Drug Discovery
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Enzyme Profiling
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Biomarker Discovery
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global Catalog Peptide Market, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1. Pharmaceutical and Biotechnology Companies
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. CROs and CMOs
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Academic and Research Institutes
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Catalog Peptide Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Catalog Peptide Market - Opportunity Analysis Index, By Peptide Type, Disease Type, Application, End User, and Region, 2023 - 2029
10. North America Catalog Peptide Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.1. Peptide Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Adrenomedullin
10.1.2. G-Protein-Coupled Receptors (GPCR)
10.1.3. Amyloid
10.1.4. Caspase Related
10.1.5. Calcitonin Gene-Related
10.1.6. Cyclic
10.1.7. Amylin
10.1.8. Tau
10.1.9. Others
10.2. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Cancer and Apoptosis
10.2.2. Cardiovascular
10.2.3. Diabetes
10.2.4. Neuroscience
10.2.5. Infectious Diseases
10.2.6. Anti-inflammatory
10.2.7. Blood Disorders
10.2.8. Others
10.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Antibody Production
10.3.2. Drug Discovery
10.3.3. Enzyme Profiling
10.3.4. Biomarker Discovery
10.3.5. Others
10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Pharmaceutical and Biotechnology Companies
10.4.2. CROs and CMOs
10.4.3. Academic and Research Institutes
10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Catalog Peptide Market - Opportunity Analysis Index, By Peptide Type, Disease Type, Application, End User, and Country, 2023 - 2029
10.7. North America Catalog Peptide Market Dynamics Trends
11. Europe Catalog Peptide Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
11.1. Peptide Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Adrenomedullin
11.1.2. G-Protein-Coupled Receptors (GPCR)
11.1.3. Amyloid
11.1.4. Caspase Related
11.1.5. Calcitonin Gene-Related
11.1.6. Cyclic
11.1.7. Amylin
11.1.8. Tau
11.1.9. Others
11.2. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Cancer and Apoptosis
11.2.2. Cardiovascular
11.2.3. Diabetes
11.2.4. Neuroscience
11.2.5. Infectious Diseases
11.2.6. Anti-inflammatory
11.2.7. Blood Disorders
11.2.8. Others
11.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Antibody Production
11.3.2. Drug Discovery
11.3.3. Enzyme Profiling
11.3.4. Biomarker Discovery
11.3.5. Others
11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Pharmaceutical and Biotechnology Companies
11.4.2. CROs and CMOs
11.4.3. Academic and Research Institutes
11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe Catalog Peptide Market - Opportunity Analysis Index, By Peptide Type, Disease Type, Application, End User, and Country, 2023 - 2029
11.7. Europe Catalog Peptide Market Dynamics Trends
12. Asia-Pacific Catalog Peptide Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
12.1. Peptide Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Adrenomedullin
12.1.2. G-Protein-Coupled Receptors (GPCR)
12.1.3. Amyloid
12.1.4. Caspase Related
12.1.5. Calcitonin Gene-Related
12.1.6. Cyclic
12.1.7. Amylin
12.1.8. Tau
12.1.9. Others
12.2. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Cancer and Apoptosis
12.2.2. Cardiovascular
12.2.3. Diabetes
12.2.4. Neuroscience
12.2.5. Infectious Diseases
12.2.6. Anti-inflammatory
12.2.7. Blood Disorders
12.2.8. Others
12.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Antibody Production
12.3.2. Drug Discovery
12.3.3. Enzyme Profiling
12.3.4. Biomarker Discovery
12.3.5. Others
12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Pharmaceutical and Biotechnology Companies
12.4.2. CROs and CMOs
12.4.3. Academic and Research Institutes
12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Catalog Peptide Market - Opportunity Analysis Index, By Peptide Type, Disease Type, Application, End User, and Country, 2023 - 2029
12.7. Asia-Pacific Catalog Peptide Market Dynamics Trends
13. Latin America Catalog Peptide Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.1. Peptide Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Adrenomedullin
13.1.2. G-Protein-Coupled Receptors (GPCR)
13.1.3. Amyloid
13.1.4. Caspase Related
13.1.5. Calcitonin Gene-Related
13.1.6. Cyclic
13.1.7. Amylin
13.1.8. Tau
13.1.9. Others
13.2. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Cancer and Apoptosis
13.2.2. Cardiovascular
13.2.3. Diabetes
13.2.4. Neuroscience
13.2.5. Infectious Diseases
13.2.6. Anti-inflammatory
13.2.7. Blood Disorders
13.2.8. Others
13.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Antibody Production
13.3.2. Drug Discovery
13.3.3. Enzyme Profiling
13.3.4. Biomarker Discovery
13.3.5. Others
13.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Pharmaceutical and Biotechnology Companies
13.4.2. CROs and CMOs
13.4.3. Academic and Research Institutes
13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Catalog Peptide Market - Opportunity Analysis Index, By Peptide Type, Disease Type, Application, End User, and Country, 2023 - 2029
13.7. Latin America Catalog Peptide Market Dynamics Trends
14. Middle East and Africa Catalog Peptide Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.1. Peptide Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Adrenomedullin
14.1.2. G-Protein-Coupled Receptors (GPCR)
14.1.3. Amyloid
14.1.4. Caspase Related
14.1.5. Calcitonin Gene-Related
14.1.6. Cyclic
14.1.7. Amylin
14.1.8. Tau
14.1.9. Others
14.2. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Cancer and Apoptosis
14.2.2. Cardiovascular
14.2.3. Diabetes
14.2.4. Neuroscience
14.2.5. Infectious Diseases
14.2.6. Anti-inflammatory
14.2.7. Blood Disorders
14.2.8. Others
14.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Antibody Production
14.3.2. Drug Discovery
14.3.3. Enzyme Profiling
14.3.4. Biomarker Discovery
14.3.5. Others
14.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Pharmaceutical and Biotechnology Companies
14.4.2. CROs and CMOs
14.4.3. Academic and Research Institutes
14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Catalog Peptide Market - Opportunity Analysis Index, By Peptide Type, Disease Type, Application, End User, and Country, 2023 - 2029
14.7. MEA Catalog Peptide Market Dynamics Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Bachem AG
15.2.2. JPT Peptide Technologies GmbH
15.2.3. AAPPTEC
15.2.4. Kaneka Eurogentec S.A.
15.2.5. Biopeptek Pharmaceuticals LLC
15.2.6. Vivitide, LLC
15.2.7. Abbiotec Inc.
15.2.8. Auspep Pty Ltd.
15.2.9. Peptides International Inc.
15.2.10. Thermo Fisher Scientific Inc.
15.2.11. GenScript Biotech Corporation
15.2.12. Creative Peptides
15.2.13. KareBay Biochem Inc.
15.2.14. Ontores Biotechnologies Inc.
15.2.15. Severn Biotech Ltd.
16. Research Methodology
17. Key Assumptions and Acronyms

Key Market Players

  • PolyPeptide Group
  • CSBio
  • GL Biochem Ltd.
  • CPC Scientific Inc.
  • Peptides International Ltd.
  • Applied Biological Materials Inc.
  • Biomatik Corporation
  • Bio-Synthesis Inc.
  • Advanced ChemTech
  • Creative Peptides

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market